A case of chronic suppurative osteomyelitis of the mandible in a child
Chronic suppurative osteomyelitis of the mandible is very rare in infants and small children. We encountered a 5-year-old boy with chronic suppurative osteomyelitis of the mandible who showed extensive mandibular destruction from the right mandibular deciduous molar region to the mandibular ramus. O...
        Saved in:
      
    
          | Published in | Pediatric Oral and Maxillofacial Surgery Vol. 8; no. 2; pp. 18 - 24 | 
|---|---|
| Main Authors | , , , , , , , , , , , | 
| Format | Journal Article | 
| Language | English Japanese  | 
| Published | 
            JAPANESE SOCIETY OF PEDIATRIC ORAL AND MAXILLOFACIAL SURGERY
    
        1998
     日本小児口腔外科学会  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0917-5261 1884-6661  | 
| DOI | 10.11265/poms1991.8.2_18 | 
Cover
| Summary: | Chronic suppurative osteomyelitis of the mandible is very rare in infants and small children. We encountered a 5-year-old boy with chronic suppurative osteomyelitis of the mandible who showed extensive mandibular destruction from the right mandibular deciduous molar region to the mandibular ramus. Orthopantomogram revealed a motheaten appearance. Osteomyelitis of the mandible which progresses causing extensive mandible destruction, is considered to affect mandibular development, and it may result in sequelae including esthetic impairment such as facial deformity and impairment of the masticatory function. However, bone remodeling is remarkable in infants and small children, and early bone regeneration can be expected. We attempted hyperbaric oxygen therapy (HBO) to promote early bone formation and minimize esthetic and functional impairment with satisfactory results. Cooperation of parents is necessary for HBO therapy for small children. It might be troublesome that the patient and parents are obliged to the stay in the HBO room during the treatment. However, our patient showed early bone regeneration. Therefore, HBO is considered to be an adjunctive treatment positively acceptable to promote bone formation for the treatment of infants and small children with bone destructive changes. | 
|---|---|
| ISSN: | 0917-5261 1884-6661  | 
| DOI: | 10.11265/poms1991.8.2_18 |